USE OF FAVIPIRAVIR IN THE MANAGEMENT OF COVID-19 2020-08-26T18:32:11+02:00Jul 22nd, 2020|MAC Advisories| Advisory on Favipiravir-22 July 2020 Rapid Review of Favipiravir for COVID-19_25June2020 facebooktwitterlinkedinwhatsappEmail Related Posts STRATEGIES TO ADDRESS COVID-19 VACCINE HESITANCY AND PROMOTE ACCEPTANCE IN SOUTH AFRICA PREPARING FOR A POTENTIAL THIRD WAVE UPDATED ADVISORY ON IVERMECTIN RECOMMENDATIONS FOR EASTER PERIOD
